
Research Memo: Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Presented to Congressional Committee Staff
Policy
On December 1, 2023, the LDI Maternal and Reproductive Health Working Group submitted a public comment in response to a Request for Information (RFI) from the U.S. Departments of the Treasury, Labor, and Health and Human Services. The RFI sought input on a proposed policy which would require insurance coverage of over-the-counter (OTC) preventive items and services without a prescription by a health care provider.
The comment highlights the obstacles that many patients, especially those from marginalized communities, face in accessing affordable birth control, and expresses the importance of and mechanisms for ensuring that OTC contraceptives are available without financial or logistical barriers.
Presented to Congressional Committee Staff
Delivered to Staff of U.S. Senate Committee on Finance
Delivered to Philadelphia City Council
Presented to Staff of U.S. Senate Committee on Finance
Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
Presented to Staff of Rep. GT Thompson (R-PA)